about
Discovery of butyrylcholinesterase inhibitors among derivatives of azaphenothiazines.Synthesis and anticancer and lipophilic properties of 10-dialkylaminobutynyl derivatives of 1,8- and 2,7-diazaphenothiazines.Synthesis and biological evaluation of novel propargylquinobenzothiazines and their derivatives as potential antiproliferative, anti-inflammatory, and anticancer agents.3,6-Diazaphenothiazines as potential lead molecules - synthesis, characterization and anticancer activity.Synthesis and anticancer activity of thiosubstituted purines.6-Substituted 9-fluoroquino[3,2-b]benzo[1,4]thiazines display strong antiproliferative and antitumor properties.Azaphenothiazines - promising phenothiazine derivatives. An insight into nomenclature, synthesis, structure elucidation and biological properties.Synthesis, spectroscopic characterization, and anticancer activity of new 10-substituted 1,6-diazaphenothiazines.Synthesis of quinoline/naphthalene-containing azaphenothiazines and their potent in vitro antioxidant properties.Synthesis and selected immunological properties of 10-substituted 1,8-diazaphenothiazines.10H-3,6-Diazaphenothiazine induces G2/M phase cell cycle arrest and caspase-dependent apoptosis and inhibits cell invasion of A2780 ovarian carcinoma cells through the regulation of NF-κB and (BIRC6-XIAP) complexes.Estimation of the lipophilicity of new anticancer and immunosuppressive 1,8-diazaphenothiazine derivatives.Lipophilicity of New Anticancer 1,6- and 3,6-diazaphenothiazines by of Use RP TLC and Different Computational Methods.Selected azaphenothiazines inhibit delayed type hypersensitivity and carrageenan reaction in mice.Synthesis and anticancer activity of multisubstituted purines and xanthines with one or two propynylthio and aminobutynylthio groups.Topically applied azaphenothiazines inhibit contact sensitivity to oxazolone in mice.10H-1,9-diazaphenothiazine and its 10-derivatives: synthesis, characterisation and biological evaluation as potential anticancer agents
P50
Q35130541-D690968A-9D67-4EF0-8A27-6DE76AFA8B9FQ38743483-5DA4D111-FB0F-4331-A9BE-CD33217D8131Q38758568-EE027867-4C33-4855-A348-64AC0367E13DQ38788378-A742CC82-56CC-4A48-B8DB-2AAB5F48AE3BQ38853858-4B553F8D-76D1-4F30-8AA3-290D3B69072DQ38933381-FBBC2CEE-32A9-42E7-9F8A-31BBAE06B6E9Q39451798-FEDE0872-A5CE-4A6F-ABE8-8DC7B7123121Q41536986-595E652C-16ED-4C71-8E1D-786DDB8D1D66Q42044231-79B4B51D-881E-43AE-A156-8348B6635043Q42182710-C8A7C387-A634-4956-8EAE-B136636F8B24Q46264412-063BAC7D-8D66-4EB3-AE4A-CAD907432905Q48684856-3D146863-DA72-439C-98F6-BF85A741D0A4Q50099117-DBA7B0F3-C233-4185-8851-C26401792732Q51503019-B05E6E0F-6725-4C63-961C-D7C16A62C0EEQ52715820-D3C54C79-EF40-48C9-8A6D-CBCC48A26A1CQ52760996-A3E32E86-6E3F-4ED9-B621-EBB064AB6E90Q91893410-4FC0EBF3-3DA6-4BC3-8AF9-2CCA544EC8B2
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Krystian Pluta
@en
Krystian Pluta
@nl
type
label
Krystian Pluta
@en
Krystian Pluta
@nl
prefLabel
Krystian Pluta
@en
Krystian Pluta
@nl
P31
P496
0000-0002-5537-0768